Search research articles
Contact Us
Filters
Showing results (181-190 of 217) with videos related to
Page
of 22
Sort By:
Carcinogenesis
|
August 30, 2000
Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization
M Muscheck, H Abol-Enein, K Chew, et al.
Urology
|
August 30, 2000
Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database
G D Grossfeld, J J Chang, J M Broering, et al.
Urology
|
April 18, 2001
Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up
G D Grossfeld, M S Litwin, J S Wolf, et al.
Prostate Cancer and Prostatic Diseases
|
May 14, 2014
Updated trends in imaging use in men diagnosed with prostate cancer
S P Porten, A Smith, A Y Odisho, et al.
The Journal of Urology
|
February 15, 2001
Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database
G D Grossfeld, J J Chang, J M Broering, et al.
Urology
|
March 15, 2001
Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database
D F Penson, W H Schonfeld, S C Flanders, et al.
The Journal of Urology
|
April 29, 1998
Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity
G D Grossfeld, A F Olumi, J A Connolly, et al.
Prostate Cancer and Prostatic Diseases
|
February 21, 2012
PSA screening: determinants of primary-care physician practice patterns
G E Tasian, M R Cooperberg, M B Potter, et al.
The Journal of Urology
|
February 1, 1993
Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression
P R Carroll, F M Waldman, W Rosenau, et al.
The Journal of Urology
|
January 28, 2015
Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes
A A Hussein, C J Welty, N Ameli, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 217) with videos related to
Sort By:
Page
of 22
Carcinogenesis
|
August 30, 2000
Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization
M Muscheck, H Abol-Enein, K Chew, et al.
Urology
|
August 30, 2000
Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database
G D Grossfeld, J J Chang, J M Broering, et al.
Urology
|
April 18, 2001
Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up
G D Grossfeld, M S Litwin, J S Wolf, et al.
Prostate Cancer and Prostatic Diseases
|
May 14, 2014
Updated trends in imaging use in men diagnosed with prostate cancer
S P Porten, A Smith, A Y Odisho, et al.
The Journal of Urology
|
February 15, 2001
Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database
G D Grossfeld, J J Chang, J M Broering, et al.
Urology
|
March 15, 2001
Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database
D F Penson, W H Schonfeld, S C Flanders, et al.
The Journal of Urology
|
April 29, 1998
Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity
G D Grossfeld, A F Olumi, J A Connolly, et al.
Prostate Cancer and Prostatic Diseases
|
February 21, 2012
PSA screening: determinants of primary-care physician practice patterns
G E Tasian, M R Cooperberg, M B Potter, et al.
The Journal of Urology
|
February 1, 1993
Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression
P R Carroll, F M Waldman, W Rosenau, et al.
The Journal of Urology
|
January 28, 2015
Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes
A A Hussein, C J Welty, N Ameli, et al.
Page
of 22